NCT01806909View on ClinicalTrials.gov

Intranasal AD4-H5-VTN as an Adenovirus Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

January 9, 2018

Study Completion Date

April 22, 2019

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Ad4-H5-Vtn

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01806909 - Intranasal AD4-H5-VTN as an Adenovirus Vaccine | Biotech Hunter | Biotech Hunter